Loading…
← CockpitCompetitor Analysis › 001328.SZ Dencare (Chongqing) Oral Care Co., Ltd. Class AOpen in the cockpit ↗

Dencare (Chongqing) Oral Care Co., Ltd. Class A001328.SZCompetitor analysis, valuation and peers

China · CNY·Consumer Staples›Household/Personal Care
Momentum leader 98
Mkt cap
$912M
US dollars, full cap
Free float
24%
of shares outstanding
$/day
$22.2M
20-day average traded
Fwd P/E
27.9×
forward earnings
ROIC−WACC
+34.6 pp
WACC 5.0%
Hurdle
-7 pp
Req g minus delivered
Next earnings
161 days
28 Apr 2027
Close · CNYCN¥34.88
1D-2.8%
1W+3.4%
1M+15.9%
3M+18.9%
6M+13.2%
YTD-11.7%
1Y-4.8%
ATR %5.2%
52w lowhigh21.4% off high

What Dencare (Chongqing) Oral Care does

Employees: 1,044

Dencare (Chongqing) Oral Care at a glance

Size Dencare (Chongqing) Oral Care (001328.SZ) is a China Consumer Staples company (Household/Personal Care) with a market value of $912M, the 2341st largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥34.88 on 18 Nov 2026.

Performance Over six months the shares gained 13.2%, against +4.3% for the median peer and -20.0% for the China market (cap-weighted) — 8th highest of 21 in its peer set.

Growth Revenue grew 10.2% over the last twelve months (peer median +11.5%); the operating margin is 10.7% (peer median 8.9%).

Valuation It trades at 27.9× forward earnings against a peer median of 18.1× (5th most expensive of 21).

Price implies For today's price to make sense, revenue must grow about 4% a year for seven years (Req g). Recent delivered growth is +11%, so the hurdle is -7 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 34.6 points above its cost of capital (5.0% WACC).

Next results Next results expected around 28 Apr 2027 (exchange calendar; dates can move).

Relative performance

8010012021 May 202621 Aug 202618 Nov 2026001328.SZ 114Peer median 107
Six months, rebased to 100: Dencare (Chongqing) Oral Care against the median of its 20 peers (local-currency closes).

Dencare (Chongqing) Oral Care financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥1.91BCN¥1.70BCN¥1.55BCN¥1.37BCN¥1.31B
Revenue growth—+10%+13%+4%—
Gross profitCN¥1.04BCN¥877MCN¥757MCN¥595MCN¥532M
EBITDAn/aCN¥189MCN¥162MCN¥117Mn/a
Net incomeCN¥206MCN¥181MCN¥161MCN¥141MCN¥135M
Free cash flowCN¥159MCN¥185MCN¥162MCN¥108MCN¥31.7M
Capital expenditureCN¥39.9MCN¥48.9MCN¥46.7MCN¥44.1MCN¥55.5M
Total debtCN¥0CN¥0CN¥0CN¥77.3MCN¥0

Quarterly statements and history in the cockpit →

Dencare (Chongqing) Oral Care competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%-25%0%+25%+50%-20%0%6031933011084928241710GALAXYSURF3007402657JYOTHYLAB49194836506050092145EPC003006ICOSBAJAJCON301371PZC002790001328.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. Dencare (Chongqing) Oral Care is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%10×20×30×40×6031933011084928241710GALAXYSURF3007402657JYOTHYLAB49194836506050092145EPC003006ICOSBAJAJCON301371PZC002790001328.SZRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Dencare (Chongqing) Oral Care is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%6031933011084928GALAXYSURF3007402657JYOTHYLAB49194836506050092145003006BAJAJCONPZC002790600315001328.SZGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Dencare (Chongqing) Oral Care is the large dot.

Dencare (Chongqing) Oral Care competitors and peer comparison

How Dencare (Chongqing) Oral Care compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Dencare (Chongqing) Oral Care against its 20 peers (data as of 18 Nov 2026)
Measure001328.SZPeer medianRank in peer set
1-month return+15.9%-3.5%highest of 21
6-month return+13.2%+4.3%8th highest of 21
Distance from 52-week high-21.4%-33.1%8th highest of 21
Revenue growth (TTM)+10.2%+11.5%11th highest of 21
Operating margin10.7%8.9%10th highest of 21
Forward P/E27.9×18.1×5th most expensive of 21
Growth the price implies (Req g, 7 yrs)3.7%5.9%8th least demanding of 19
Growth delivered (Del g)+10.8%+7.9%8th highest of 19
Hurdle (Req g minus delivered)-7.0 pp-1.7 pp8th least demanding of 19
ROIC minus cost of capital+34.6 pp+6.2 pp5th highest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Dencare (Chongqing) Oral Care 001328.SZChina$912M+13%+10%11%27.9×3.7%+10.8%
Runben Biotechnology 603193.SSChina$918M-30%+13%21%18.5×1.5%+28.4%
Tongling Jieya Biologic Technology 301108.SZChina$933M+56%+24%5%52.5×28.5%+0.8%
Noevir 4928.TJapan$978M+7%-3%28%20.4×-12.8%+4.1%
Cosmecca Korea 241710.KSSouth Korea$847M+23%+42%12%16.3×n/an/a
Galaxy Surfactants GALAXYSURF.NSIndia$845M+22%+30%9%17.6×18.5%+13.7%
SYoung 300740.SZChina$816M-48%+14%3%33.4×14.0%+6.1%
Shanghai Forest Cabin Cosmetics 2657.HKHong Kong$1.04B+15%+74%18%11.8×11.3%+49.0%
Jyothy Labs JYOTHYLAB.NSIndia$762M-9%+5%8%40.8×34.5%+8.9%
Milbon 4919.TJapan$743M+48%+8%14%25.7×-3.3%+8.2%
d'Alba Global 483650.KSSouth Korea$1.13B-55%+49%22%12.0×-6.6%+53.0%
Hangzhou Haoyue Personal Care 605009.SSChina$726M-18%+10%6%17.7×4.4%+7.7%
Shanghai Chicmax Cosmetics 2145.HKHong Kong$1.17B-42%+23%8%14.4×-6.1%+21.2%
Edgewell Personal Care EPCUnited States$1.30B+67%-10%7%14.2×n/an/a
Chongqing Baiya Sanitary Products 003006.SZChina$1.35B+27%0%3%37.3×28.8%+22.8%
Intercos ICOS.MIItaly$1.43B+12%-5%9%18.9×4.3%+11.5%
Bajaj Consumer Care BAJAJCON.NSIndia$560M-24%+29%22%19.7×14.8%+5.0%
Harbin Fuerjia Technology 301371.SZChina$1.51B-39%+28%20%21.4×7.5%+3.6%
PZ Cussons PZC.LUnited Kingdom$527M+13%+5%11%12.7×-2.3%-2.1%
AMOREPACIFIC 002790.KSSouth Korea$1.61B+2%+9%9%8.5×-5.7%-1.3%
Shanghai Jahwa United 600315.SSChina$1.61B-15%+9%2%15.4×15.3%-2.1%

Questions

Which companies are Dencare (Chongqing) Oral Care's closest peers?
The cockpit's peer set: Runben Biotechnology (603193.SS), Tongling Jieya Biologic Technology (301108.SZ), Noevir (4928.T), Cosmecca Korea (241710.KS), Galaxy Surfactants (GALAXYSURF.NS), SYoung (300740.SZ), Shanghai Forest Cabin Cosmetics (2657.HK), Jyothy Labs (JYOTHYLAB.NS).
Is Dencare (Chongqing) Oral Care expensive compared with its peers?
On forward p/e it trades at 27.9× against a peer median of 18.1×, 5th most expensive of 21 in its peer set. For today's price to make sense, revenue must grow about 4% a year for seven years (Req g). Recent delivered growth is +11%, so the hurdle is -7 pp: the price already allows for a slowdown.
How has Dencare (Chongqing) Oral Care stock performed?
Over six months to 18 Nov 2026 the shares returned +13.2% against +4.3% for the median peer; over one year -4.8%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.